Published in Allergy on January 25, 2011
Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol (2011) 1.91
A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. J Allergy Clin Immunol (2013) 1.18
Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: implications in atopic dermatitis. PLoS One (2012) 0.92
The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis. JAKSTAT (2013) 0.90
Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment. J Immunol (2012) 0.86
Trp channels and itch. Semin Immunopathol (2015) 0.83
Eccrine sweat contains IL-1α, IL-1β and IL-31 and activates epidermal keratinocytes as a danger signal. PLoS One (2013) 0.82
IL-31 does not induce normal human ciliated epithelial cells to differentiate into a phenotype consistent with the pathophysiology of asthma. Results Immunol (2012) 0.78
Solanum tuberosum L. cv Hongyoung extract inhibits 2,4‑dinitrochlorobenzene‑induced atopic dermatitis in NC/Nga mice. Mol Med Rep (2016) 0.75
Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol (2016) 0.75
The association of interleukin-31 polymorphisms with interleukin-31 serum levels and risk of systemic lupus erythematosus. Rheumatol Int (2016) 0.75
The Role of Intereukin-31 in Pathogenesis of Itch and Its Intensity in a Course of Bullous Pemphigoid and Dermatitis Herpetiformis. Biomed Res Int (2017) 0.75
Primary prevention of food allergy in children and adults: systematic review. Allergy (2014) 2.75
The inhomogeneous structure of water at ambient conditions. Proc Natl Acad Sci U S A (2009) 2.31
The diagnosis of food allergy: a systematic review and meta-analysis. Allergy (2013) 2.23
EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy (2014) 2.05
The epidemiology of food allergy in Europe: a systematic review and meta-analysis. Allergy (2013) 2.02
Standardization of food challenges in patients with immediate reactions to foods--position paper from the European Academy of Allergology and Clinical Immunology. Allergy (2004) 1.81
Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol (2012) 1.77
Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy (2014) 1.73
Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol (2002) 1.62
A subset of CD8+ T cells from allergic patients produce IL-4 and stimulate IgE production in vitro. Clin Exp Allergy (1997) 1.51
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II. J Eur Acad Dermatol Venereol (2012) 1.49
The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy (2004) 1.42
Digital ultraviolet therapy: a novel therapeutic approach for the targeted treatment of psoriasis vulgaris. Br J Dermatol (2015) 1.39
Increased metal allergy in patients with failed metal-on-metal hip arthroplasty and peri-implant T-lymphocytic inflammation. Allergy (2009) 1.37
ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol (2009) 1.19
Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol (1999) 1.16
Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy (2005) 1.14
Encephalitis in a stone marten (Martes foina) after natural infection with highly pathogenic avian influenza virus subtype H5N1. J Comp Pathol (2007) 1.13
Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol (2009) 1.09
Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy (2000) 1.09
C5a suppresses the production of IL-12 by IFN-gamma-primed and lipopolysaccharide-challenged human monocytes. J Immunol (1999) 1.07
Histamine H4 receptors modulate dendritic cell migration through skin--immunomodulatory role of histamine. Allergy (2008) 1.05
Bacterial infections and atopic dermatitis. Allergy (2001) 1.02
EAACI/GA2LEN position paper: present status of the atopy patch test. Allergy (2006) 1.02
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02
Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy (2004) 1.01
Circulating levels of brain-derived neurotrophic factor correlate with disease severity in the intrinsic type of atopic dermatitis. Allergy (2006) 0.99
Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol (1998) 0.99
Expression of interleukin (IL)-1 family members upon stimulation with IL-17 differs in keratinocytes derived from patients with psoriasis and healthy donors. Br J Dermatol (2011) 0.98
Anaphylatoxin C3a but not C3a(desArg) is a chemotaxin for the mouse macrophage cell line J774. Eur J Immunol (1998) 0.95
Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy (2005) 0.95
Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies. Immunology (1999) 0.95
Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model. Allergy (2012) 0.94
The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells. Immunology (2000) 0.94
Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism. Allergy (2008) 0.93
Sensitive detection of Borrelia burgdorferi sensu lato DNA and differentiation of Borrelia species by LightCycler PCR. J Clin Microbiol (2001) 0.92
Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria. Int Arch Allergy Immunol (1998) 0.92
Interleukin-1 from epithelial cells fosters T cell-dependent skin inflammation. Br J Dermatol (2010) 0.91
Detection of clonal T cell receptor gamma gene rearrangements in cutaneous T cell lymphoma by LightCycler-polymerase chain reaction. J Invest Dermatol (2001) 0.90
Murine and human Langerhans cells express a functional histamine H4 receptor: modulation of cell migration and function. Allergy (2009) 0.90
Interleukin (IL)-31 induces pro-inflammatory cytokines in human monocytes and macrophages following stimulation with staphylococcal exotoxins. Allergy (2009) 0.89
Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy (2007) 0.89
The role of circulating food antigen-specific lymphocytes in food allergic children with atopic dermatitis. Br J Dermatol (1996) 0.88
Detection of anaphylatoxin receptors on CD83+ dendritic cells derived from human skin. Immunology (2001) 0.87
Atopy patch test reactions are associated with T lymphocyte-mediated allergen-specific immune responses in atopic dermatitis. Clin Exp Allergy (1999) 0.87
Acute and long-term management of food allergy: systematic review. Allergy (2013) 0.86
Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy. Br J Dermatol (2005) 0.86
High frequency of vitamin D deficiency among patients with cutaneous lupus erythematosus [corrected]. Br J Dermatol (2008) 0.85
Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis. Allergy (2009) 0.85
The incidence of atopic dermatitis in school entrants is associated with individual life-style factors but not with local environmental factors in Hannover, Germany. Br J Dermatol (2002) 0.84
Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol (2001) 0.84
Therapy of noninfectious granulomatous skin diseases with fumaric acid esters. Br J Dermatol (2005) 0.84
C3a(desArg) does not bind to and signal through the human C3a receptor. Immunol Lett (1999) 0.84
Suppression of interleukin-12 production by human monocytes after preincubation with lipopolysaccharide. Blood (1999) 0.84
Specific detection by flow cytometry of histidine-tagged ligands bound to their receptors using a tag-specific monoclonal antibody. J Immunol Methods (1999) 0.83
Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. A preliminary study. Psychother Psychosom (1998) 0.83
Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy (2010) 0.83
Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu. Allergy (2014) 0.83
No effect of anti-interleukin-5 therapy (mepolizumab) on the atopy patch test in atopic dermatitis patients. Int Arch Allergy Immunol (2006) 0.83
Blood- and skin-derived monocytes/macrophages respond to C3a but not to C3a(desArg) with a transient release of calcium via a pertussis toxin-sensitive signal transduction pathway. Eur J Immunol (1997) 0.82
Birch pollen-related food as a provocation factor of allergic symptoms in children with atopic eczema/dermatitis syndrome. Allergy (2004) 0.82
The human mast cell line HMC-1 binds and responds to C3a but not C3a(desArg). Scand J Immunol (1998) 0.82
[Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506)]. Hautarzt (2001) 0.82
[Education programs on atopic eczema. Design and first results of the German Randomized Intervention Multicenter Study]. Hautarzt (2003) 0.82
Different expression of cytokine and membrane molecules by circulating lymphocytes on acute mental stress in patients with atopic dermatitis in comparison with healthy controls. J Allergy Clin Immunol (2001) 0.82
Validity study for the stigmatization experience in atopic dermatitis and psoriatic patients. Acta Derm Venereol (1999) 0.82
Profiling of histamine H4 receptor agonists in native human monocytes. Br J Pharmacol (2013) 0.82
Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life. J Eur Acad Dermatol Venereol (2012) 0.81
[Successful treatment of subcorneal pustular type of IgA pemphigus]. Hautarzt (2005) 0.80
Intracellular staining of Mx proteins in cells from peripheral blood, bone marrow and skin. Mol Pathol (1997) 0.80
Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy (2001) 0.79
Deficiency in immunoglobulin G2 antibodies against staphylococcal enterotoxin C1 defines a subgroup of patients with atopic dermatitis. Clin Exp Allergy (2005) 0.79
[Cutaneous side effects of EGF-receptor inhibition and their management]. Hautarzt (2006) 0.79
Interleukin-33 modulates the expression of human β-defensin 2 in human primary keratinocytes and may influence the susceptibility to bacterial superinfection in acute atopic dermatitis. Br J Dermatol (2012) 0.79
[Successful topical treatment of cutaneous sarcoidosis with tacrolimus]. Hautarzt (2003) 0.79
Successful treatment of anogenital Bowen's disease with the immunomodulator imiquimod, and monitoring of therapy by DNA image cytometry. Br J Dermatol (2002) 0.79
Immunological effects of stress in psoriasis. Br J Dermatol (2008) 0.78
[Successful symptomatic treatment of epidermodysplasia verruciformis with imiquimod 5% cream]. Hautarzt (2010) 0.78
Macrophages from patients with atopic dermatitis show a reduced CXCL10 expression in response to staphylococcal α-toxin. Allergy (2011) 0.78
Specificity of tyrosinase and HMB45 PCR in the detection of melanoma metastases in sentinel lymph node biopsies. Histopathology (2002) 0.78
In vivo diagnosis of allergic diseases--allergen provocation tests. Allergy (2015) 0.78
[Associations between bioaerosols coming from livestock facilities and asthmatic symptoms in children]. Gesundheitswesen (2006) 0.78
The role of T-cell reactivity towards the autoantigen α-NAC in atopic dermatitis. Br J Dermatol (2011) 0.78
[Specific immunotherapy and atopic dermatitis. What is new?]. Hautarzt (2011) 0.77
[Hematogenous contact eczema induced by foods]. Hautarzt (2006) 0.77
[Depression and anxiety disorders among psoriasis patients: protective and exacerbating factors]. Hautarzt (2014) 0.77
[Evidence-based and consented guideline on allergy prevention]. J Dtsch Dermatol Ges (2004) 0.76
Systematic review and evidence-based consensus guideline on prevention of allergy and atopic eczema of the German Network on Allergy Prevention (ABAP). Minerva Pediatr (2008) 0.76
[New and rarley used treatment options for refractory hand eczema: local UVA-1 phototherapy, retinoids, calcineurin inhibitors]. Hautarzt (2008) 0.76
Cutaneous manifestations of Takayasu arteritis. Acta Derm Venereol (1996) 0.75
[Atopic dermatitis and psychological stress]. Hautarzt (2003) 0.75
Delayed-type hypersensitivity rash from paracetamol. Contact Dermatitis (2000) 0.75
[Specific immunotherapy (SIT) in atopic dermatitis and food allergy]. Hautarzt (2008) 0.75